Related Experiment Video

Updated: Jul 16, 2026

Visualizing Leukocyte Rolling and Adhesion in Angiotensin II-Infused Mice: Techniques and Pitfalls
10:16

Visualizing Leukocyte Rolling and Adhesion in Angiotensin II-Infused Mice: Techniques and Pitfalls

Published on: January 4, 2018

Vascular inflammation in hypertension and diabetes: molecular mechanisms and therapeutic interventions

Carmine Savoia1, Ernesto L Schiffrin

  • 1Lady Davis Institute for Medical Research, Sir Mortimer B. Davis-Jewish General Hospital, McGill University, Montreal, QC, Canada.

Clinical Science (London, England : 1979)
|February 28, 2007
PubMed

Insights

Hypertension and type 2 diabetes significantly increase cardiovascular risks. Managing blood pressure and inflammation in these patients is crucial for reducing cardiovascular events and mortality.

Area of Science:

  • Cardiovascular Medicine
  • Endocrinology
  • Nephrology

Background:

  • Hypertension and type 2 diabetes mellitus frequently coexist, significantly increasing cardiovascular morbidity and mortality.
  • This combination represents a major public health challenge due to shared risk factors and complex pathophysiology.

Purpose of the Study:

  • To explore the multifactorial pathophysiology of cardiovascular disease in patients with coexisting hypertension and diabetes.
  • To highlight the role of low-grade inflammation, oxidative stress, and the renin-angiotensin system in this patient population.

Main Methods:

  • Review of recent evidence linking inflammation, oxidative stress, and cardiovascular disease in hypertensive and diabetic patients.
  • Discussion of the role of Angiotensin II in promoting vascular inflammation and endothelial dysfunction.
  • Examination of inflammatory markers (e.g., C-reactive protein, chemokines, adhesion molecules).

Main Results:

  • Elevated blood pressure in diabetic hypertensive individuals is linked to increased cardiovascular events.
  • A low-grade inflammatory process, driven by factors like Angiotensin II and oxidative stress, significantly contributes to cardiovascular disease pathophysiology.
  • Increased levels of inflammatory markers predict cardiovascular disease development in patients with hypertension and metabolic disorders.

Conclusions:

  • Lowering blood pressure in diabetic hypertensive patients reduces cardiovascular events.
  • Targeting inflammation and the renin-angiotensin system, alongside lifestyle modifications, is essential for managing cardiovascular risk in patients with hypertension and metabolic disorders.
  • Interventions aimed at reducing blood pressure and inflammation can decrease cardiovascular morbidity and mortality.

Related Concept Videos

Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...